Trials / Terminated
TerminatedNCT07105332
Feasibility Trial of a Sub-conjunctival Insert
Investigation of a Sub-Conjunctival Insert
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 8 (actual)
- Sponsor
- EyeSense GmbH · Industry
- Sex
- All
- Age
- 16 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this single-centre, open label prospective study is to investigate a novel ocular mini insert (OMI) for detection of blood glucose levels in human subjects. First, the optimal technical parameters for measurement are determined on healthy subjects. Secondly, performance measurements follow investigating relationship between OMI signal and blood glucose in diabetes patients during short sessions with oral glucose tolerace test.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | OMI and Photometer | A glucose sensitive ocular mini insert (OMI) is placed sub-conjunctivaly. When exited by photometer the glucose concentration is measured. |
Timeline
- Start date
- 2006-12-01
- Primary completion
- 2008-06-01
- Completion
- 2008-07-01
- First posted
- 2025-08-05
- Last updated
- 2025-08-05
Source: ClinicalTrials.gov record NCT07105332. Inclusion in this directory is not an endorsement.